TransCode Therapeutics In... (RNAZ)
NASDAQ: RNAZ
· Real-Time Price · USD
10.56
-0.01 (-0.14%)
At close: Oct 03, 2025, 3:58 PM
10.58
0.14%
After-hours: Oct 03, 2025, 06:32 PM EDT
-0.14% (1D)
| Bid | 9.6 |
| Market Cap | 8.81M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -24.6M |
| EPS (ttm) | -61.43 |
| PE Ratio (ttm) | -0.17 |
| Forward PE | -1.17 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 10.87 |
| Volume | 5,564 |
| Avg. Volume (20D) | 89,606 |
| Open | 10.72 |
| Previous Close | 10.57 |
| Day's Range | 10.32 - 10.74 |
| 52-Week Range | 6.15 - 739.20 |
| Beta | 1.51 |
| Ex-Dividend Date | n/a |
About RNAZ
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RNAZ
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RNAZ stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
-21.22%
TransCode Therapeutics shares are trading lower af...
Unlock content with
Pro Subscription
5 months ago
-9.18%
TransCode Therapeutics shares are trading lower after the company announced a 1-for-28 reverse stock split
